pharmaphorum
DECEMBER 4, 2020
Pfizer will pay up to $45 million in development related milestone payments and up to $143 million if the vaccine hits early sales targets. Under the agreement Valneva could receive up to $308 million in cash payments, after Pfizer paid $130 million up front for marketing rights to the vaccine if it succeeds in the clinic.
Pharmaceutical Technology
OCTOBER 28, 2022
According to the UK’s National Health Service (NHS), there are over 90 strains of this bacterium. According to GlobalData, Pharmaceutical Technology’s parent company, Prevnar 13 and Vaxneuvance are forecasted to have global sales of $7.26 VAX-24 has forecasted sales of $21 million in the same year. Further plans in the making.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 19, 2022
Now, Synlogic has reported phase 2 results of two non-absorbed strains of the bacterium Escherichia coli Nissle used as probiotics – codenamed SYNB1618 and SYNB1934 – which have been engineered to break down phe in the gastrointestinal tract.
XTalks
JULY 28, 2021
Compared to Vaxneuvance’s targeting of 15 different strains of the bacterium, Pfizer’s shot protects against 20. billion in sales in 2020 and has been outselling Merck’s previous shot, Pneumovax 23, by almost five to one. This is seven more strains than its current winning vaccine Prevnar 13, which registered $5.95
pharmaphorum
MAY 31, 2022
billion in sales last year. The pandemic and the timing of US government purchases for immunisation campaigns trimmed back sales from almost $5.9 billion in the previous year, but revenues bounced back in the first quarter of 2022, rising 59% to $1.57
XTalks
APRIL 15, 2025
coli s unique circular DNA during transcription is highly specific to that bacterium. The company expects these milestones to support its newly raised 2031 sales target of over 40billion ($50billion). Wood says AMR is less of a broad concern with Blujepa compared to other drug classes, as its mechanism targeting E.
Pharma in Brief
NOVEMBER 20, 2023
Instead, the Natural Health Products Regulations ( NHP Regulations ) govern the sale, manufacture, packaging, labelling, importation, distribution, and storage of natural health products. In its August 16, 2023 decision in Le-Vel Brands, LLC v.
Expert insights. Personalized for you.
119 
Let's personalize your content